Dublin, Dec. 08, 2022 (GLOBE NEWSWIRE) -- The "Medical Aesthetics Market by Product, End User - Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.
The medical aesthetics market is projected to reach $29.43 billion by 2029, at a CAGR of 10.4% from 2022 to 2029.
After extensive primary and secondary research, the report provides an in-depth analysis of the medical aesthetics market. The report also provides insights on the key drivers, restraints, challenges, and opportunities in the medical aesthetics market.
The growing adoption of minimally invasive & noninvasive aesthetic procedures, rising adoption of aesthetic procedures among the elderly to improve their appearance, and the increasing public awareness about cosmetic procedures are some of the major factors driving this market's growth.
Furthermore, rising adoption of aesthetic procedures in emerging economies and the growing adoption of home-use aesthetic devices are expected to provide significant opportunities for the growth of this market. However, the social stigma associated with cosmetic procedures hampers the growth of this market to a notable extent.
Based on product, in 2022, the facial aesthetic products segment is expected to account for the largest share of the medical aesthetics market. The large market share of this segment is attributed to people's growing interest in enhancing their facial features and the wide availability of advanced facial aesthetic products.
Based on end user, in 2022, the hospitals, clinics, and medical spas segment is expected to account for the largest share of the medical aesthetics market. The large market share of this segment is attributed to the proliferation of hospitals and clinics equipped with advanced aesthetic devices and aesthetic specialists and the increasing number of medical spas.
In 2022, North America is expected to account for the largest share of the medical aesthetics market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
The key players operating in the medical aesthetics market are
- Anika Therapeutics Inc. (U.S.)
- Cutera Inc. (U.S.)
- Galderma SA (Switzerland)
- El.En. S.p.A. (Italy)
- Merz Pharma GmbH & Co. KGaA (Germany)
- Cynosure Inc. (U.S.)
- Mentor Worldwide LLC (U.S.)
- Allergan plc (Ireland)
- Alma Lasers (Israel)
- Fotona D.O.O (Slovenia)
- Sientra Inc. (U.S.)
- Sinclair Pharma (U.K.)
- Candela Medical (U.S.)
- Sciton Inc. (U.S.)
- Revance Therapeutics Inc. (U.S.)
- Solta Medical (U.S.)
Key Topics Covered:
1. Introduction
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Process
2.2. Data Collection & Validation
2.3. Market Assessment
2.4. Assumptions for the Study
2.5. Limitations for the Study
3. Executive Summary
4. Market Insights
4.1. Introduction
4.2. Drivers
4.2.1. Growing Adoption of Minimally Invasive & Noninvasive Aesthetic Procedures
4.2.2. Rising Adoption of Aesthetic Procedures Among the Elderly to Improve their Appearance
4.2.3. Increasing Public Awareness About Cosmetic Procedures
4.3. Restraints
4.3.1. Risks and Complications Associated with Medical Aesthetic Procedures
4.4. Opportunities
4.4.1. Growing Adoption of Home-use Aesthetic Devices
4.4.2. Rising Adoption of Aesthetic Procedures in Emerging Economies
4.5. Challenges
4.5.1. Social Stigmas Associated with Cosmetic Procedures
4.6. Market Trends
4.6.1. Integration of Artificial Intelligence (AI) and Robotics Technologies into Medical Aesthetics
4.7. The Impact of COVID-19 on the Global Medical Aesthetics Market
5. Regulatory Analysis
5.1. North America
5.2. Europe
5.3. Asia-Pacific
5.4. Latin America
5.5. Middle East & Africa
6. Global Medical Aesthetics Market, by Product
6.1. Introduction
6.2. Facial Aesthetics Products
6.2.1. Botulinum Toxin
6.2.2. Dermal Fillers
6.2.3. Chemical Peels
6.2.4. Microdermabrasion Devices
6.2.5. Acne Treatment Devices
6.3. Cosmetic Implants
6.3.1. Breast Implants
6.3.1.1. Silicon Implants
6.3.1.2. Saline Implants
6.3.2. Facial Implants
6.3.3. Other Cosmetic Implants
6.4. Body Contouring Devices
6.4.1. Non-surgical Fat Reduction Devices
6.4.2. Liposuction Devices
6.4.3. Cellulite Reduction Devices
6.4.4. Body Shaping Devices
6.5. Physician-dispensed Cosmeceuticals, Skin Lighteners, and Eyelash Products
6.6. Aesthetics Skin Devices
6.6.1. Non-surgical Skin Tightening Devices
6.6.2. Laser Skin Resurfacing Devices
6.6.3. Light Therapy Devices
6.6.4. Micro-needling Products
6.7. Hair Removal Devices
6.7.1. Laser Hair Removal Devices
6.7.2. IPL Hair Removal Devices
6.8. Tattoo Removal Devices
6.9. Thread Lift Products
6.10. Nail Treatment Laser Devices
7. Global Medical Aesthetics Market, by End User
7.1. Introduction
7.2. Hospitals, Clinics, and Medical Spas
7.3. Beauty Centers
7.4. Home Care Settings
8. Global Medical Aesthetics Market, by Geography
8.1. Introduction
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.3. Europe
8.3.1. Germany
8.3.2. U.K.
8.3.3. Italy
8.3.4. France
8.3.5. Spain
8.3.6. Rest of Europe
8.4. Asia-Pacific
8.4.1. China
8.4.2. Japan
8.4.3. South Korea
8.4.4. India
8.4.5. Thailand
8.4.6. Rest of Asia-Pacific
8.5. Latin America
8.5.1. Brazil
8.5.2. Mexico
8.5.3. Rest of Latin America
8.6. Middle East & Africa
9. Competitive Landscape
9.1. Introduction
9.2. Key Growth Strategies
9.3. Competitive Benchmarking
10. Company Profiles
For more information about this report visit https://www.researchandmarkets.com/r/vfumi1
